Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study
dc.contributor.author | Eraksoy, Mefkure | |
dc.contributor.author | Akman, Gülşen Demir | |
dc.contributor.author | Agan, Kadriye | |
dc.contributor.author | Günal, Dilek İnce | |
dc.contributor.author | Us, Önder | |
dc.contributor.author | Şaip, Sebahattin | |
dc.contributor.author | Demirci, Nuri Onat | |
dc.contributor.author | Tütüncü, Melih | |
dc.contributor.author | Boz, Cavit | |
dc.contributor.author | Terzi, Matthew C. | |
dc.contributor.author | Onar, Musa | |
dc.contributor.author | Aydin, H. Güngör | |
dc.contributor.author | Türk, U. Boru | |
dc.contributor.author | Soysal, Aysun | |
dc.contributor.author | Petek, Belgin Balcı | |
dc.contributor.author | Türkoğlu, Recai | |
dc.contributor.author | Dib, Hussein | |
dc.contributor.author | Siva, Aksel | |
dc.contributor.buuauthor | Turan, Ömer Faruk | |
dc.contributor.buuauthor | Taşkapılıoğlu, Özlem | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı. | tr_TR |
dc.date.accessioned | 2022-06-09T05:47:00Z | |
dc.date.available | 2022-06-09T05:47:00Z | |
dc.date.issued | 2009-10 | |
dc.description.sponsorship | Bu çalışma, 24-30 Ekim 2009 tarihleri arasında Bangkok[Tayland]’da düzenlenen 19. World Congress of Neurology’da bildiri olarak sunulmuştur. | en_US |
dc.identifier.citation | Eraksoy, M. vd. (2009). "Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study". Journal of the Neurological Sciences, 285(Supplement 1), S209-S209. | en_US |
dc.identifier.endpage | S209 | tr_TR |
dc.identifier.issn | 0022-510X | |
dc.identifier.issue | Supplement 1 | en_US |
dc.identifier.startpage | S209 | tr_TR |
dc.identifier.uri | https://doi.org/10.1016/S0022-510X(09)70798-1 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0022510X09707981 | |
dc.identifier.uri | http://hdl.handle.net/11452/26979 | |
dc.identifier.volume | 285 | tr_TR |
dc.identifier.wos | 000272521300731 | tr_TR |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Journal of the Neurological Sciences | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject.wos | Clinical neurology | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.title | Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study | en_US |
dc.type | Article | |
dc.wos.quartile | Q2 (Clinical neurology) | en_US |
dc.wos.quartile | Q3 (Neurosciences) | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: